Home » National Institutes Of Health » NIH » Science and Research » FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease January 6, 2024 Medline-NIH Off National Institutes Of Health, NIH, Science and Research Source: Food and Drug AdministrationRelated MedlinePlus Pages: Sickle Cell Disease Read Original Article: FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease » Previous: Coping with Divorce Next: Placebo Effect About The Author Medline-NIH